Simvastatin attenuates the activity of matrix metalloprotease-9 in aneurysmal aortic tissue.

[1]  Jeroen J. Bax,et al.  Statins are associated with a reduced infrarenal abdominal aortic aneurysm growth. , 2006, European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery.

[2]  W. Aronow,et al.  Mortality and size of abdominal aortic aneurysm at long-term follow-up of patients not treated surgically and treated with and without statins. , 2006, The American journal of cardiology.

[3]  N. Hagiwara,et al.  A 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor, cerivastatin, suppresses production of matrix metalloproteinase-9 in human abdominal aortic aneurysm wall. , 2002, Journal of vascular surgery.

[4]  J. Powell,et al.  Inflammation and matrix metalloproteinases in the enlarging abdominal aortic aneurysm. , 1995, Arteriosclerosis, thrombosis, and vascular biology.

[5]  F. Bernini,et al.  HMG-CoA reductase inhibitors reduce MMP-9 secretion by macrophages. , 1998, Arteriosclerosis, thrombosis, and vascular biology.